ECGFF yields 1000.00% · MRK yields 2.76%● Live data
📍 ECGFF pulled ahead of the other in Year 1
Combined, ECGFF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ECGFF + MRK for your $10,000?
EcoGraf Limited engages in building a diversified battery anode material business that produces graphite products for the clean energy and lithium-ion battery markets in Asia, Europe, and North America. It develops HFfree purification technology, which produces battery anode material to support electric vehicle, battery, and anode manufacturers. The company also provides EcoGraf purification process that enables battery supply chain customers to reduce their CO2 emissions and lower battery costs. In addition, it is involved in the developing of TanzGraphite natural flake graphite business through its Epanko Graphite Project in Tanzania, which offers flake graphite products for industrial applications. The company was formerly known as Kibaran Resources Limited and changed its name to EcoGraf Limited in December 2019. EcoGraf Limited was incorporated in 2005 and is headquartered in West Perth, Australia.
Full ECGFF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.